Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and ...
Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer Largest real-world, blinded, multi-site validation of AI molecular profiling from ...
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...
BERKELEY, Calif. and MAINZ, Germany, July 15, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...
For decades, large portions of the human genome were labeled "junk DNA." New research from Western University and London ...
In a new study published in Science Signaling, University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings ...
Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...
Q4 2025 Management View CEO Sean McCarthy highlighted an update on Phase I dose expansion data for Varseta-M, the company's EpCAM-targeting PROBODY antibody drug conjugate for colorectal cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results